Bajaj Healthcare [BAJAJHCARE] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Bajaj Healthcare

NSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bajaj Healthcare wins in 6 metrics, Aarti Drugs wins in 14 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bajaj Healthcare Aarti Drugs Better
P/E Ratio (TTM) 31.35 24.62 Aarti Drugs
Price-to-Book Ratio 3.20 3.39 Bajaj Healthcare
Debt-to-Equity Ratio 47.89 44.92 Aarti Drugs
PEG Ratio 0.71 0.39 Aarti Drugs
EV/EBITDA 21.03 17.69 Aarti Drugs
Profit Margin (TTM) 7.90% 7.80% Bajaj Healthcare
Operating Margin (TTM) 12.68% 10.11% Bajaj Healthcare
EBITDA Margin (TTM) 12.68% 10.11% Bajaj Healthcare
Return on Equity 8.47% 12.28% Aarti Drugs
Return on Assets (TTM) 4.74% 6.53% Aarti Drugs
Free Cash Flow (TTM) $100.82M $674.22M Aarti Drugs
Dividend Yield 0.19% 0.22% Aarti Drugs
1-Year Return 23.92% -0.29% Bajaj Healthcare
Price-to-Sales Ratio (TTM) 2.67 1.92 Aarti Drugs
Enterprise Value $17.39B $52.33B Aarti Drugs
EV/Revenue Ratio 3.11 2.16 Aarti Drugs
Gross Profit Margin (TTM) 45.85% 36.77% Bajaj Healthcare
Revenue per Share (TTM) $182 $265 Aarti Drugs
Earnings per Share (Diluted) $15.08 $20.65 Aarti Drugs
Beta (Stock Volatility) 0.18 0.16 Aarti Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bajaj Healthcare vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Bajaj Healthcare
Aarti Drugs
Bajaj Healthcare Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bajaj Healthcare-0.30%-2.08%10.16%-2.88%-16.33%-25.63%
Aarti Drugs1.34%4.17%3.26%6.50%57.69%11.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bajaj Healthcare23.92%34.09%29.32%29.32%29.32%29.32%
Aarti Drugs-0.29%10.41%-35.67%241.44%2,724.44%3,165.25%

News Based Sentiment: Bajaj Healthcare vs Aarti Drugs

Bajaj Healthcare

News based Sentiment: MIXED

October presented a mixed bag for Bajaj Healthcare, with strong earnings reports offset by a high valuation, declining market share, and conflicting analyst recommendations. The regulatory announcement adds another layer of uncertainty, making it a significant but complex month for investors.

View Bajaj Healthcare News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Bajaj Healthcare vs Aarti Drugs

MetricBAJAJHCAREAARTIDRUGS
Market Information
Market Cap i₹15.16B₹47.07B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i311,834150,245
90 Day Avg. Volume i367,909183,982
Last Close₹468.80₹515.20
52 Week Range₹333.80 - ₹745.00₹312.00 - ₹564.05
% from 52W High-37.07%-8.66%
All-Time High₹745.00 (Mar 17, 2025)₹1,026.95 (Oct 05, 2020)
% from All-Time High-37.07%-49.83%
Growth Metrics
Quarterly Revenue Growth0.13%0.06%
Quarterly Earnings Growth0.66%0.62%
Financial Health
Profit Margin (TTM) i0.08%0.08%
Operating Margin (TTM) i0.13%0.10%
Return on Equity (TTM) i0.08%0.12%
Debt to Equity (MRQ) i47.8944.92
Cash & Liquidity
Book Value per Share (MRQ)₹147.63₹149.84
Cash per Share (MRQ)₹1.41₹2.48
Operating Cash Flow (TTM) i₹13.95M₹2.83B
Levered Free Cash Flow (TTM) i₹394.96M₹1.68B
Dividends
Last 12-Month Dividend Yield i0.19%0.22%
Last 12-Month Dividend i₹1.00₹1.00

Valuation & Enterprise Metrics Analysis: Bajaj Healthcare vs Aarti Drugs

MetricBAJAJHCAREAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i31.3524.62
Forward P/E iN/A15.85
PEG Ratio i0.710.39
Price to Sales (TTM) i2.671.92
Price to Book (MRQ) i3.203.39
Market Capitalization
Market Capitalization i₹15.16B₹47.07B
Enterprise Value i₹17.39B₹52.33B
Enterprise Value Metrics
Enterprise to Revenue i3.112.16
Enterprise to EBITDA i21.0317.69
Risk & Other Metrics
Beta i0.180.16
Book Value per Share (MRQ) i₹147.63₹149.84

Financial Statements Comparison: Bajaj Healthcare vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BAJAJHCAREAARTIDRUGS
Revenue/Sales i₹1.49B₹5.91B
Cost of Goods Sold i₹805.88M₹3.73B
Gross Profit i₹682.48M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹188.73M₹593.60M
EBITDA i₹253.87M₹743.90M
Pre-Tax Income i₹145.25M₹511.10M
Income Tax i₹23.51M₹-28.60M
Net Income (Profit) i₹118.34M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BAJAJHCAREAARTIDRUGS
Cash & Equivalents i₹26.04M₹45.77M
Total Current Assets i₹5.61B₹13.38B
Total Current Liabilities i₹2.97B₹8.37B
Long-Term Debt i₹649.19M₹2.86B
Total Shareholders Equity i₹4.66B₹13.69B
Retained Earnings i₹3.04B₹12.40B
Property, Plant & Equipment i₹2.37B₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BAJAJHCAREAARTIDRUGS
Operating Cash Flow i₹7.46MN/A
Capital Expenditures i₹-66.96MN/A
Free Cash Flow i₹5.04MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase i₹0N/A

Short Interest & Institutional Ownership Analysis

MetricBAJAJHCAREAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i311,834150,245
Average Daily Volume (90 Day) i367,909183,982
Shares Outstanding i31.58M91.27M
Float Shares i10.14M39.04M
% Held by Insiders i0.64%0.60%
% Held by Institutions i0.02%0.11%

Dividend Analysis & Yield Comparison: Bajaj Healthcare vs Aarti Drugs

MetricBAJAJHCAREAARTIDRUGS
Last 12-Month Dividend i₹1.00₹1.00
Last 12-Month Dividend Yield i0.19%0.22%
3-Year Avg Annual Dividend i₹1.17₹1.00
3-Year Avg Dividend Yield i0.29%0.23%
3-Year Total Dividends i₹3.50₹3.00
Ex-Dividend DateSep 23, 2024Feb 04, 2025